Dislog Group expands its healthcare portfolio with the acquisition of 75% of Megaflex
Dislog Group, a leading player in distribution and logistics in Morocco, announced its acquisition of a 75% stake in Megaflex, a renowned company specializing in medical devices. This acquisition, which received the green light from the Moroccan Competition Council, marks a significant step in Dislog Group’s strategy to strengthen its presence in the healthcare sector.
Strategic Acquisition to Boost Healthcare Division
Nacer Amrani, the founder of Megaflex, will retain a 25% stake and continue to co-manage the company for the next three years as part of a structured transition. With this acquisition, Megaflex is now part of the Medical Device Division under Dislog Health Care, which is directed by Nadia Lahlou. This addition brings new expertise to the division, enhancing Dislog Group’s ability to address the needs of medical laboratories and healthcare professionals across Morocco.
About Megaflex: Leader in Medical Device Distribution
Established in 1992, Megaflex has been a pioneering force in Morocco’s medical equipment distribution market. The company provides high-quality equipment, reagents, and services to public and private research laboratories, along with in vitro diagnostic laboratories. Through strong partnerships with leading international manufacturers, Megaflex offers solutions across various medical disciplines, including Hematology, Hemostasis, Urine Cytology, Biochemistry, Immuno-analysis, Molecular Biology, Next-Generation Sequencing (NGS), and Immuno-hematology. The company also plays a key role in advancing predictive, personalized, and precision medicine, particularly with the NGS technology provided by Illumina.
Creating a Full Healthcare Value Chain
With the integration of Megaflex, Dislog Group’s Healthcare Division now covers a comprehensive value chain—from the manufacturing of medicines to the distribution of specialized equipment for healthcare institutions. This chain also includes other Dislog entities, such as Kosmopharm, Steripharma, and AFRICARE, all working together to support the fast-growing healthcare sector in Morocco.
Statements from Industry Leaders
Moncef Belkhayat, CEO of Dislog Group, expressed enthusiasm for this strategic move: “We are thrilled to welcome Megaflex into the Dislog family. This acquisition provides a significant growth opportunity, enabling us to consolidate our position as a national leader in Morocco’s healthcare sector. The integration of Megaflex opens up numerous opportunities for our clients and partners.”
On the other hand, Nacer Amrani, founder of Megaflex, stated, “Joining forces with Dislog Group marks a pivotal moment for Megaflex. This strategic partnership will allow us to accelerate our growth while remaining true to our founding values and ambitions. Together, we will achieve new milestones in the medical device sector, impacting the industry with innovation and growth.”
Financial and Legal Advisors for the Acquisition
Dislog Group was financially advised by Fintrust Capital, represented by Moncef Benzakour, and legally supported by lawyer Rachid Hilmi. Nacer Amrani received financial advice from Arden Capital, represented by Amine El Azher, and legal counsel from DLA Piper, with key representation from Benoit de Monval.
A Promising Future for Morocco’s Healthcare Industry
With this acquisition, Dislog Group is strategically positioned to offer a broader range of products and services to healthcare professionals. The integration of Megaflex strengthens the group’s expertise in the medical field and reflects its commitment to meeting the growing demands of healthcare providers and laboratories in Morocco. This step highlights Dislog Group’s vision to contribute to the development of a robust healthcare system capable of addressing current and future medical challenges in the region.
